Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Chiasma nets $94.7mm in oversubscribed IPO

Executive Summary

Chiasma Inc. (oral orphan drugs for diseases requiring frequent dosing) netted $94.7mm in its initial public offering of 6.4mm shares at $16, above its anticipated sale of 5.4mm shares at a $13-15 range. Some existing investors bought 1.7mm of the IPO shares.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies